Strategic CDMO Partner Phillips Medisize positions itself as a contract development and manufacturing organization with global scale (30 sites, 6,000+ employees) and a track record supporting leading pharmaceutical, medtech, and in vitro diagnostic companies. Sales opportunities lie in multi-site program execution, complex regulatory pathways, and integrated design-to-manufacture partnerships that can consolidate vendors for customers seeking efficiency and speed to market.

Inhalation and Diagnostics Recent activity highlights emphasis on inhalation and dry powder inhaler capabilities as well as in vitro diagnostic devices, suggesting growth in respiratory drug delivery and point-of-care diagnostics. Target opportunities include pharma and medtech clients looking to scale complex inhalation products or expand diagnostic portfolios with CDMO support from early development through manufacturing.

Connectivity and Integration Launch of TheraVolt Medical Connectors and collaborations for device connectivity indicate a strategic push into next-generation device integration. This opens sales avenues with device manufacturers seeking integrated hardware and connectivity solutions, as well as peripherals and integration-tested platforms to ensure reliable interoperability.

Global Manufacturing Footprint With 30 development and manufacturing sites across three continents and partnerships (e.g., TactoTek IMSE collaboration), Phillips Medisize can offer geographically diversified production, supply chain resilience, and regional regulatory navigation. Prospects include multinational programs requiring nearshore or offshore manufacturing, risk diversification, and coordinated global launches.

Industry Collaboration Active involvement with industry events (ADLM, RDD conferences) and partnerships with leaders like Medtronic, Abbott, and Boston Scientific signals strong market credibility and demand for scalable, compliant manufacturing solutions. Use these signals to approach large medtech and diagnostic players seeking to expand or co-develop complex products under a CDMO umbrella.